UCB's Global Corporate Website

UCB supports launch of the IOF SCOPE-2021 report about the increasing burden of osteoporosis and inequality of care in Europe

Adriaan Snauwaert resized
Posted by
Adriaan Snauwaert, Global Communications & Company Reputation


The International Osteoporosis Foundation published its Scorecard for Osteoporosis in Europe (SCOPE) 2021 report which describes the epidemiology, burden, and treatment of osteoporosis in each of the 27 countries of the European Union plus Switzerland and the UK revealing startling statistics:

  • For every minute that passes eight new fracture cases arise in the EU. 

  • It is estimated that more than 23 million people are at high risk of osteoporotic fractures in the European Union. 

  • Osteoporosis and the 4.3 million fragility fractures that it causes cost the health care systems of Europe in excess of €56 billion each year based on data for 2019. Only 3% of this money was spent on medical treatment.

The SCOPE-2021 report aims to highlight the burden of disease in addition to gaps and inequalities in the provision of healthcare for osteoporosis in Europe. The call to action is for a Europe-wide strategy and parallel national strategies to provide coordinated osteoporosis care to reduce fragility fractures and their impact on individual lives, society and the healthcare system.

Together with the IOF and national osteoporosis societies, UCB is committed to raising awareness of the increasing burden of osteoporosis in Europe in addition to highlighting the inequality of care and access to osteoporosis medication. UCB is working hand-in-hand with the IOF to ensure that this report is widely disseminated and reaches key stakeholders such as patients, healthcare providers, payers and policy makers.

Through our Capture the Fracture partnership with the IOF, we can engage key stakeholders in these countries around the call-to-action to understand what support they will need to improve the quality of osteoporosis care including access to timely risk assessments and effective treatment options.

In addition, UCB is amplifying the key findings from the SCOPE-2021 report on Twitter and LinkedIn this week and will continue to support the dissemination over the coming months during key congresses and events. Please support by sharing and retweeting posts. For more information you can read the full SCOPE report here: SCOPE report.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.